Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Xiangju Pharmaceutical Group is a leading Chinese pharmaceutical enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM) and modern pharmaceuticals. The company is most recognized for its flagship product, Xiangju Capsules (Xiangju Jiaonang), which is a nationally protected TCM variety widely prescribed for the treatment of acute and chronic sinusitis and rhinitis. Beyond respiratory health, the group maintains a diverse portfolio covering pediatric medicine, cardiovascular treatments, and anti-infectives. Headquartered in Shangluo, Shaanxi, the company operates large-scale GMP-certified manufacturing facilities and has established a comprehensive domestic distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 陕西香菊药业集团.